Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Braintree Manufacturing Innovation Centre: A case study in GMP transformational change

The Cell and Gene Therapy Catapult’s (CGT Catapult) Braintree Manufacturing Innovation Centre (Braintree MIC) is designed to support cell and gene therapy developers to accelerate the development of their Good Manufacturing Practice (GMP) manufacturing operations for advanced therapies at a clinical and commercial scale.

Following a successful inspection by the Medicines and Healthcare products Regulatory Agency (MHRA), Braintree MIC received an MHRA Manufacturers and Importers Authorisation for Investigational Medicinal Products (MIA(IMP)) and associated GMP certificate.

This license allows therapy developers collaborating at the site in Braintree to develop their own advanced therapy manufacturing capabilities and contribute to the growing number of advanced therapy medicinal products (ATMPs) that are being developed, manufactured, and exported annually in the UK.

Published on the 12th of september 2024. Read the full news report following this link.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (19 novembre 2024). Braintree Manufacturing Innovation Centre: A case study in GMP transformational change. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/12prs


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.